ChemicalBook > Product Catalog >Biochemical Engineering >Nucleoside drugs >Deoxynucleotides and their analogs >6-Mercaptopurine-2'-deoxyriboside

6-Mercaptopurine-2'-deoxyriboside

Request For Quotation
6-Mercaptopurine-2'-deoxyriboside Suppliers list
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com
Company Name: Anhui kuer Bioengineering Co., Ltd  
Tel: 0551-65171243 13856024262
Email: kuer@kuerhuaxue.com
Company Name: Shenzhen Regent Biochemical Technology Co., Ltd.  
Tel: 0755-85201366 18938635012
Email: sales@regentsciences.com
Company Name: Shenzhen Polymeri Biochemical Technology Co., Ltd.  
Tel: +86-400-002-6226
Email: sales@rrkchem.com
Company Name: Zhengzhou Granlen Sciences, ltd.  
Tel: 0371-85513397 +86-18610099868
Email: info@granlen.com

6-Mercaptopurine-2'-deoxyriboside manufacturers
6-Mercaptopurine-2'-deoxyriboside Basic information
Product Name:6-Mercaptopurine-2'-deoxyriboside
Synonyms:2’-deoxy-6-thio-inosin;2’-deoxy-6-thioinosine;6-mercaptopurinedeoxyriboside;9-(2-deoxy-beta-d-erythro-pentofuranosyl)-9h-purine-6(1h)-thiol;9-(2-deoxy-beta-d-erythro-pentofuranosyl)-9h-purine-6(1h)-thion;6-MERCAPTOPURINE-2'-DEOXYRIBONUCLEOSIDE;DEOXYTHIOINOSINE;6-Mercaptopurine-2′-deoxyriboside ,98%
CAS:2239-64-7
MF:C10H12N4O3S
MW:268.29
EINECS:
Product Categories:Biochemicals and Reagents;Nucleoside Analogs;Nucleosides, Nucleotides, Oligonucleotides
Mol File:2239-64-7.mol
6-Mercaptopurine-2'-deoxyriboside Structure
6-Mercaptopurine-2'-deoxyriboside Chemical Properties
Melting point 184-186 °C
Boiling point 665.9±65.0 °C(Predicted)
density 1.87±0.1 g/cm3(Predicted)
storage temp. −20°C
pka8.40±0.20(Predicted)
Safety Information
Hazard Codes Xn
Risk Statements 22
Safety Statements 36
WGK Germany 3
RTECS UP0762000
HS Code 29349990
MSDS Information
ProviderLanguage
SigmaAldrich English
6-Mercaptopurine-2'-deoxyriboside Usage And Synthesis
Chemical Propertiessolid
Uses2′-Deoxy-6-thioinosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
6-Mercaptopurine-2'-deoxyriboside Preparation Products And Raw materials
Preparation Products2'-deoxynebularine
Tag:6-Mercaptopurine-2'-deoxyriboside(2239-64-7) Related Product Information
6-Thioguanosine 6-Thioguanosine hydrate 6-[(4-Nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine-5'-monophosphate, disodium salt 6-Mercaptopurine-2'-deoxyriboside 2-Amino-6-chloro-[(4-methylphenyl)thio]-9-(2',3',5'-tri-O-acetyl-beta-D-ribofuranosyl)purine S-(2-Hydroxy-5-nitrobenzyl)-6-thioguanosine S-(4-Nitrobenzyl)-6-thioinosine S-(2-Hydroxy-5-nitrobenzyl)-6-thioinosine 6-Mercaptopurine riboside 6-Methylmercaptopurine riboside 2',3'-O-Isopropylidene-6-thioinosine NBTGR sulfinosine 6-(2-Pyridylmethylthio)-9-beta-D-ribofuranosyl-9H-purine 6-Mercaptopurine arabinoside 2-Amino-6-mercapto-9-(2',3',5'-tri-O-acetyl-β-ribofuranosyl)purine S-(p-Nitrobenzyl)-6-thioinosine, [3H]- 6-Mercapto-2',3',5'-triacetylpurine riboside